Clinical Trial Update: TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating transarterial chemoembolization (TACE) as adjuvant therapy after radiofrequency ablation for hepatocellular carcinoma. The status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 4 | Status: UNKNOWN